Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,920 | -3,875 | -2,650 | -1,320 | -5,480 |
| Depreciation Amortization | 70 | 56 | 37 | 18 | 60 |
| Other Working Capital | -250 | -412 | -291 | -457 | 440 |
| Other Operating Activity | 250 | 232 | 67 | 161 | 590 |
| Operating Cash Flow | $-4,850 | $-3,999 | $-2,837 | $-1,598 | $-4,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -33 | -29 | -8 | -160 |
| Investing Cash Flow | $-30 | $-33 | $-29 | $-8 | $-160 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 952 | 796 | N/A | N/A | 7,548 |
| Other Financing Activity | -42 | -36 | 0 | 0 | -128 |
| Financing Cash Flow | $910 | $760 | $N/A | $N/A | $7,420 |
| Beginning Cash Position | 5,290 | 5,293 | 5,293 | 5,293 | 2,420 |
| End Cash Position | 1,310 | 2,021 | 2,427 | 3,687 | 5,290 |
| Net Cash Flow | $-3,970 | $-3,272 | $-2,866 | $-1,605 | $2,860 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,850 | -3,999 | -2,837 | -1,598 | -4,390 |
| Capital Expenditure | -33 | -33 | -29 | -8 | -162 |
| Free Cash Flow | -4,883 | -4,032 | -2,866 | -1,605 | -4,552 |